Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Tegretol CR (carbamazepine) Treatment Report
What is Tegretol CR?

Tegretol CR, an international brand name, is an extended release preparation of carbamazepine. It is used for of seizure disorders and trigeminal neuralgia. Off label uses include treatment of resistant schizophrenia, alcohol withdrawal, restless leg syndrome and post-traumatic stress disorder.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Trigeminal neuralgia 3 1
Severe tingling numbness burning in my feet and hands 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
1 100%
Mild
0 0%
None
0 0%

Most commonly reported side effects

Nausea/Vomiting
1 100%
Sleepiness
1 100%
  • Mild
  • Moderate
  • Severe

Dosages

  100 mg daily 400 mg daily 800 mg daily 1200 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Tegretol CR (multiple reasons could be selected)
Reason # Patients Percentage of patients
Personal research
1 100% Personal research: 100%
Doctor's advice
1 100% Doctor's advice: 100%
Other
1 100% Other: 100%

See all 1 patient who’ve stopped taking Tegretol CR

Currently Taking Tegretol CR

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
2
0
0

Stopped Taking Tegretol CR

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
1
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
1 100%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 100%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.